In the Health-care & Pharmaceutical industries, data growth is generated from several sources, including the R&D process itself, retailers, patients, and caregivers.
Effectively utilizing these data will help pharmaceutical companies better identify new potential drug candidates and develop them into effective, approved and reimbursed medicines more quickly.
Let’s imagine the vision, However many pharmaceutical companies are wary about investing significantly in improving big-data analytical capabilities, partly because there are few examples of peers creating a lot of value from it.
